Batm Advanced Communicat... Share Discussion Threads

[cumnor] 25/5/2022 15:52

Lets hope its just part of the Stateside tech sell off-if the BOD and Zvi are up to no good, which would be surprising imo, it wont do sentiment towards Israelis or Israeli companies listing anywhere else any good-except in Tel Aviv maybe.

[gbenson1] 25/5/2022 15:24

There is certainly something going on here we are not aware of, why organise a share buyback programme and only use it once in 2 months? There have been too many examples of shoddy management by the company & shore capital. We shareholders deserve to be told the current situation be it good or bad news!

[kooba] 25/5/2022 15:24

Down 52% ytd.

[kooba] 25/5/2022 15:19

The only thing that makes sense on the lack of buyback is that they are working on some corporate shakeup ..unfortunately the share price action does not support any short term value enhancing event ..even with backdrop of market. I hope they are not letting this drift to try a low ball buy out and hence preserving the cash in the business ..what would be a low ball ? Anyway i know nothing just guessing but all rather disappointing ..tempted to add more but just don't have much incentive as the price doesn't seem to have any support right now and the markets are still very edgy.

[cumnor] 25/5/2022 15:04

Can Zvi be trusted at all?

[mcmather] 25/5/2022 14:57

The proposed buyback “forms part of the Board's broader strategy to deliver shareholder value”. It was passed in the general meeting 17 March 2022. Closing share price that day was 50.7p. Current share price is 38.8p. 23.47% lower. The Board's broader strategy to deliver shareholder value...

[fse] 25/5/2022 14:41

really ! just what is going on here.
We have not heard a word out of the company in some time now.
OK the market is really bad and its not up to the company to comment on its current valuation but this is well into unexplainable territory.
The news flow just went silent ......

I cant see why they would not be buying shares back at these levels unless they have information that would materially effect the share price when/if it is released.
I am well out of ideas.

[kooba] 22/5/2022 08:16

https://apple.news/AA7i2_5TPRJqKehBa8XqtxA

[kooba] 22/5/2022 08:14

Be very surprised if Ador don’t have a isolating test for Monkeypox available soon if they don’t have one already. I initially ignored the threat as it seemed that human to human transmission was very low..it seems this strain in more easily transmitted from the small amount i have read. But detection of viral pathogens could prove important early as there is a protracted incubation period before the symptoms. Just saying could refocus investors attention pathogen detection companies that are laid low as the CVD19 pandemic subdues.PCR test seems the easiest was to detect..so other subsid’s could also figure…from last year on CVD19 test..could be similar measures rolled out?
“The test has been developed by the Group’s Adaltis subsidiary and Gamidor Diagnostics (“Gamidor̶1;). Gamidor is part of the Gamida for Life B.V. group that is also a partner in the Group’s Ador Diagnostics associate company. The rapid test is being marketed under the Adaltis brand and sold under a revenue-share agreement with Gamidor. Production has commenced at Gamidor’s facility in Israel with initial deliveries being to public health authorities. Negotiations are also underway to establish another production line for this test in Europe.”

“ Confirmation of monkeypox depends on the type and quality of the specimen and the type of laboratory test. Thus, specimens should be packaged and shipped in accordance with national and international requirements. Polymerase chain reaction (PCR) is the preferred laboratory test given its accuracy and sensitivity. For this, optimal diagnostic samples for monkeypox are from skin lesions – the roof or fluid from vesicles and pustules, and dry crusts. Where feasible, biopsy is an option. Lesion samples must be stored in a dry, sterile tube (no viral transport media) and kept cold. PCR blood tests are usually inconclusive because of the short duration of viremia relative to the timing of specimen collection after symptoms begin and should not be routinely collected from patients.”
WHO latest recommendation.

[echoridge] 21/5/2022 14:53

The dream scenario of course is if the event delaying the engagement of a daily buyback is a consequential deal for Telco. Wouldn't that just kill multiple birds with a single large stone. Too ramp-y?

[fse] 20/5/2022 17:34

Kooba yes it is early and not perhaps optimum timing if they were to move to NASDAQ today. However its an option that should be considered and thats why I mentioned the conflict of interests.
I just feel Telco will get far more traction in the US particularly with the restrictions put on 5G. The move to edge computing and low latency solutions is rapidly gaining speed.
Telco was successful in the past and they were supplying the likes of Nokia networks and Alcatel. We had a Telecommunications crash and so many big names went to the wall. Telco stayed in business but had the market cut out from under them by association with those who did not read the writing on the wall.
The recent rebrand to Telco is at a development age now that they should see positive results.

[kooba] 20/5/2022 16:26

Sounds slightly early for telco to fly the nest alone if they are at inflection point starting to see some traction..especially in this market..however the absence of buy back still indicates to me that they could be shuffling the pack and telco could well be involved. Going to look at telco and its markets in more detail.

[fse] 20/5/2022 16:18

Good post kooba.
As I have commented on before that prior to the Russell Index fiasco it was an issue but not a real problem. Now I think thats changed and they need to sort this out.
Its really not my area of expertise ... I just think its untidy.
Telco moving to NASDAQ is an option that should be discussed.
It does not have any effect in BATM synergies or moving staff around.
Leaving the medical on TASE and LSE also probably sensible.




Just reposting Wizz link from above regarding Nexcom.
Telco have several licensing agreements in place and Telco CEO Ariel Efrati commented in an interview a few months ago that they were starting to see initial revenue from these sources.
This really is a trickle at the moment but deployment is starting to gain pace.
Telco have been very active in marketing and appear to me to have a more "professional" approach with their presentations.

In any event its all gone from drawing board to POC to deployment. The heavy lifting has been done and more importantly paid for.

[kooba] 20/5/2022 11:29

You cannot criticise Shore without including Zvi to an extent after all he is a very long standing non- executive director of Shore Capital . I personally do not believe holding this position shows any real independence in advisors and I’m pretty sure would be frowned on in corporate governance code. Many companies often look at their advisors and make changes to just freshen things up on a relatively regular basis obviously including their Brokers. If a company believes the market is undervaluing their stock or that alternative markets and structures might benefit from more appropriate advice then it might be the first thing that a company should consider. When the founder and ceo sits on the advisors board then maybe those conversations do not take place..they should do.

[wizzkid211] 20/5/2022 08:34

Remember...
hxxps://www.newswire.ca/news-releases/nexcom-and-telco-systems-roll-out-pre-installed-5g-iot-solution-for-virtual-edge-services-management-854960416.html

[car1pet] 19/5/2022 15:26

FSE you've criticised Shore Capital before and you may have a point but the issue is not the broker. The issue is the management of the company as I've said on many posts.
Share price is driven by company value and right now the company may have a strong balance sheet but its not perceived by the market as a company worth investing in. As Ive said before I'm holding because I believe it has good products and IP but needs a dynamic management team to exploit the products/IP and deliver growth and profit. It needs to separate medical from telco.
For me its very simple either a takeover by a competent organisation or replacement of senior management team. Odier is the largest shareholder and I believe should be instigating change. All IMO DYOR

[echoridge] 19/5/2022 15:05

goodness me, fse, I really don't know where to start. Obviously, I share your frustration but not your diagnosis. As a broker, Shore s*cks, no doubt, but unfortunately, you would be hard pressed to find a London house, big or small, that didn't these days. The rest of your analysis, I'm afraid, is just not plausible. Old man Shore having a stake in Ador is frankly, neither here nor there. It has been properly disclosed, but even if it weren't, I really can't understand your 'conflict' argument. Neither Shore nor Shore Capital have any incentive to advise against a NASDAQ listing as the UK list would nonetheless remain (believe me, NO ONE wants a de-list from the LSE) so Shore Capital would earn a fee for facilitating the listing and then still be able to cover the shares here. Old man Shore would likewise not have any reason to object. Besides, the reason the Company hasn't done it yet is simply that they think it is a needless expense and cumbersome. fwiw, I don't think Zvi gives a fig what Shore Cap think on a topic like this anyway. If he really wanted to do it, he would have. Bottom-line: no conspiracy, just poor service to date.

[fse] 19/5/2022 14:30

We are living in tough times again no one is doubting that. I sold everything (share wise) with the exception of BATM back about 12 months ago and have been holding a large amount of cash making virtually no returns.
I retained a lot of BATM shares and bought a lot recently @43p, I figured they would take a hit along with the general market.
The company though is in a growth sector with plenty of cash reserves. BATM should have been a defensive stock.

We are off worse than most tech shares due to Shore Capital duff advice over 2 or 3 years about the index. BATM decided to buy back shares in the company and this is very much the domaine of the company broker .
The company are clearly not buying back their shares or they have a serious issue with their broker.
I maintain that Shore Capital have conflicting issues here and should not be acting as the company broker.
The conflicting interests are that they are a UK based brokerage that would oppose a move to NASDAQ for all or part of the company in Telco systems case.
Their involvement in ADOR needs to be clearly spelled out.
My feeling is that they have made a difficult period very much worse.
Its also a fact that they don't interact on behalf of the company... no brokerage notes no updates just the occasional badly worded inaccurate piece of tripe.
They dont reply to calls and make no introductions or even pass requests on to the company.

[sandy789] 19/5/2022 12:51

Wherever the nasdaq goes imagine

[car1pet] 19/5/2022 11:57

So where is it going next?